InsidersTradesSigma
Browse the complete record of transactions filed by Gurrola Sandra M, Chairman & CEO. Officer active across 1 companies, notably Brooklyn ImmunoTherapeutics, Inc.. Cumulatively, 1 reports have been recorded. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Sandra M. Gurrola serves as the Chief Executive Officer and Vice President of Finance at Brooklyn ImmunoTherapeutics, Inc. In this role, she oversees the company's operations and financial strategy. Brooklyn ImmunoTherapeutics, Inc. specializes in developing immunotherapeutic treatments. Sandra leverages her expertise to guide the company towards sustainable growth.